Coupling CD16 signaling and ADAM17 inhibition in NK cells via the mAb Medi-1 markedly enhances their activation and proliferation by IL-15 as an approach to augment NK cell anti-tumor activityJOURNAL OF IMMUNOLOGYIF3.42025-11-010PRE
Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cellsJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62024-07-240OAAI
Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict MortalityCLINICAL CANCER RESEARCHIF10.22023-01-095OAAI
A PHASE I STUDY OF HCW9218, A BIFUNCTIONAL TGFb ANTAGONIST/IL-15 PROTEIN COMPLEX, IN ADVANCED SOLID TUMORSJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62022-11-070OA
SYNERGISTIC APPROACH TO OVERCOME THE SOLID TUMOR MICROENVIRONMENT OF MESOTHELIOMA WITH NATURAL KILLER CELL-FOCUSED IMMUNOTHERAPYJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62022-11-070OA
TRI-SPECIFIC KILLER ENGAGERS TARGET NATURAL KILLER CELLS TOWARDS MESOTHELIOMAJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62022-11-070OA
ENHANCING NK CELL FUNCTION IN THE `COLD' TUMOR MICROENVIRONMENT OF PROSTATE CANCER WITH A NOVEL TRI-SPECIFIC KILLER ENGAGER AGAINST PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA)JOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62022-11-070OA
HYPOXIA REPROGRAMS NATURAL KILLER CELLS AND IMPAIRS THEIR THERAPEUTIC POTENTIALJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62021-11-100OA
GTB-3550 TRI-SPECIFIC KILLER ENGAGER TRIKE™ DRIVES NK CELLS EXPANSION AND CYTOTOXICITY IN ACUTE MYELOID LEUKEMIA (AML) AND MYELODYSPLASTIC SYNDROMES (MDS) PATIENTSJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62021-11-1017OA
TARGETING PAN-TUMOR ASSOCIATED ANTIGEN B7H3 VIA COMBINATION OF TRI-SPECIFIC KILLER ENGAGER AND OFF-THE-SHELF NK CELL THERAPY ENHANCES SPECIFICITY AND FUNCTION AGAINST A BROAD RANGE OF SOLID TUMORSJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62020-11-092PREAI
OXYGEN CONCENTRATION ALTERS NATURAL KILLER CELL PHENOTYPE AND FUNCTION IN THE SOLID TUMOR MICROENVIRONMENTJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62020-11-090OAAI
Targeting KIR Blockade in Multiple Myeloma: Trouble in Checkpoint Paradise?CLINICAL CANCER RESEARCHIF10.22016-10-3116OAAI